2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Decheng Capital Global Healthcare Fund (Master), LP | 10% Owner | 4,958,810 | Apr 9, 2024 |
| Decheng Capital Global Healthcare GP, LLC | 10% Owner | 4,958,810 | Apr 9, 2024 |
| Cui Xiangmin | 10% Owner | 4,958,810 | Apr 9, 2024 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | 4,958,810 | Apr 9, 2024 |
| Decheng Capital Management IV (Cayman), LLC | 10% Owner | 4,958,810 | Apr 9, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6, 2026 | Kuan Arthur | CEO | Sell | 22.5 | -2,871 | -2.07% | ✗ | $176.9K |
| Jan 9, 2026 | Jan 13, 2026 | Mulay James | Director | Sell | 10.0 | -11,145 | -100.00% | ✓ | $584.8K |
| Nov 24, 2025 | Nov 26, 2025 | Rossi Christina | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 26, 2025 | Rossi Christina | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 24, 2025 | DETORE JAMES M. | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 17, 2025 | Nov 18, 2025 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $41.4K |
| Oct 13, 2025 | Oct 15, 2025 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $43.3K |
| Oct 9, 2025 | Oct 10, 2025 | Mulay James | Director | Sell | 7.5 | -5,903 | -100.00% | ✓ | $259.7K |
| Sep 30, 2025 | Oct 1, 2025 | POST LEONARD E | Director | Sell | 10.0 | -5,000 | -100.00% | ✓ | $200.5K |
| Sep 29, 2025 | Sep 30, 2025 | Mulay James | Director | Sell | 7.5 | -12,755 | -100.00% | ✓ | $499.9K |
| Sep 18, 2025 | Sep 22, 2025 | Mulay James | Director | Sell | 7.5 | -22,686 | -100.00% | ✓ | $884.9K |
| Sep 15, 2025 | Sep 16, 2025 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $35.1K |
| Sep 11, 2025 | Sep 15, 2025 | Liu Brian Guan-Chyun | Director | Buy | 100.0 | +1,515,151 | 100.00% | ✗ | $50M |
| Sep 5, 2025 | Sep 8, 2025 | Mulay James | Director | Sell | 7.5 | -27,015 | -100.00% | ✓ | $851.8K |
| Sep 3, 2025 | Sep 4, 2025 | Song Hong Fang | Director | Sell | 17.5 | -100,000 | -1.40% | ✗ | $2.8M |
| Sep 3, 2025 | Sep 4, 2025 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $28K |
| Aug 6, 2025 | Lapetina Bob | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 17, 2025 | Jul 18, 2025 | POST LEONARD E | Director | Sell | 10.0 | -2,000 | -100.00% | ✓ | $56K |
| Jun 5, 2025 | Jun 6, 2025 | Graf Susan E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | POST LEONARD E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Song Hong Fang | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Mulay James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Liu Brian Guan-Chyun | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Tong Victor Edward Jr | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 21, 2025 | May 22, 2025 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $28K |
| Apr 28, 2025 | Apr 29, 2025 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $30.8K |
| Apr 15, 2025 | Apr 16, 2025 | Kuan Arthur | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 15, 2025 | Apr 16, 2025 | Bellete Ambaw | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 15, 2025 | Apr 16, 2025 | Kasturi Vijay | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 15, 2025 | Apr 16, 2025 | Patterson Joshua F. | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 15, 2025 | Apr 16, 2025 | Roche Corleen M. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 17, 2025 | Mar 18, 2025 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $28K |
| Feb 18, 2025 | Feb 19, 2025 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $28.6K |
| Jan 13, 2025 | Jan 14, 2025 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $29.7K |
| Dec 16, 2024 | Dec 17, 2024 | Song Hong Fang | Director | Sell | 15.0 | -700,000 | -14.27% | ✗ | $19.6M |
| Dec 16, 2024 | Dec 17, 2024 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $28.8K |
| Dec 6, 2024 | Dec 6, 2024 | POST LEONARD E | Director | Sell | 13.8 | -1,000 | -100.00% | ✓ | $34.5K |
| Oct 4, 2024 | Oct 8, 2024 | Roche Corleen M. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2024 | Oct 7, 2024 | POST LEONARD E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2024 | Oct 7, 2024 | Graf Susan E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2024 | Oct 7, 2024 | Liu Brian Guan-Chyun | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2024 | Oct 7, 2024 | Tong Victor Edward Jr | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2024 | Oct 7, 2024 | Kasturi Vijay | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2024 | Oct 7, 2024 | Song Hong Fang | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2024 | Oct 7, 2024 | Mulay James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2024 | Oct 7, 2024 | Bellete Ambaw | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2024 | Oct 7, 2024 | Patterson Joshua F. | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2024 | Oct 7, 2024 | Kuan Arthur | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 29, 2024 | Aug 30, 2024 | Song Hong Fang | Director | Sell | 15.0 | -650,455 | -11.71% | ✗ | $23M |
| May 15, 2024 | May 16, 2024 | Patterson Joshua F. | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 16, 2024 | Patterson Joshua F. | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 29, 2024 | Apr 9, 2024 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Buy | 96.3 | +400,000 | 8.77% | ✗ | $7.6M |
| Jan 29, 2024 | Jan 31, 2024 | Kasturi Vijay | Chief Medical Officer | Buy | 91.3 | +1,315 | 100.00% | ✗ | $25K |
| Jan 29, 2024 | Jan 31, 2024 | Roche Corleen M. | CFO | Buy | 91.3 | +2,000 | 100.00% | ✗ | $38K |
| Jan 29, 2024 | Jan 31, 2024 | Song Hong Fang | Director | Buy | 100.0 | +263,157 | 75.02% | ✗ | $5M |
| Jan 29, 2024 | Jan 31, 2024 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Buy | 100.0 | +400,000 | 100.00% | ✗ | $7.6M |
| Jan 24, 2024 | Jan 26, 2024 | Roche Corleen M. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Liu Brian Guan-Chyun | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Bellete Ambaw | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Kuan Arthur | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Roche Corleen M. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Song Hong Fang | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | POST LEONARD E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Kasturi Vijay | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Graf Susan E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Tong Victor Edward Jr | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Mulay James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |